ES545270A0 - Un procedimiento para la obtencion de piridoindoles - Google Patents

Un procedimiento para la obtencion de piridoindoles

Info

Publication number
ES545270A0
ES545270A0 ES545270A ES545270A ES545270A0 ES 545270 A0 ES545270 A0 ES 545270A0 ES 545270 A ES545270 A ES 545270A ES 545270 A ES545270 A ES 545270A ES 545270 A0 ES545270 A0 ES 545270A0
Authority
ES
Spain
Prior art keywords
piridoindoles
procedure
obtaining
obtaining piridoindoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545270A
Other languages
English (en)
Other versions
ES8605271A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Publication of ES545270A0 publication Critical patent/ES545270A0/es
Publication of ES8605271A1 publication Critical patent/ES8605271A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES545270A 1983-09-21 1985-07-16 Un procedimiento para la obtencion de piridoindoles Expired ES8605271A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333994 DE3333994A1 (de) 1983-09-21 1983-09-21 Neue pyridoindolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
ES545270A0 true ES545270A0 (es) 1986-03-16
ES8605271A1 ES8605271A1 (es) 1986-03-16

Family

ID=6209594

Family Applications (2)

Application Number Title Priority Date Filing Date
ES536003A Granted ES536003A0 (es) 1983-09-21 1984-09-18 Piridoindoles
ES545270A Expired ES8605271A1 (es) 1983-09-21 1985-07-16 Un procedimiento para la obtencion de piridoindoles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES536003A Granted ES536003A0 (es) 1983-09-21 1984-09-18 Piridoindoles

Country Status (12)

Country Link
US (1) US4564613A (es)
EP (1) EP0140070A1 (es)
JP (1) JPS6087256A (es)
KR (1) KR850002269A (es)
AU (1) AU3320184A (es)
DE (1) DE3333994A1 (es)
DK (1) DK448784A (es)
ES (2) ES536003A0 (es)
FI (1) FI843672A7 (es)
HU (1) HUT36119A (es)
PT (1) PT79220B (es)
ZA (1) ZA847400B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415540D0 (en) * 1984-06-18 1984-07-25 Fujisawa Pharmaceutical Co Imidazoisoquinoline compounds
US4958023A (en) * 1988-09-19 1990-09-18 American Home Products Corporation 2-pyridinecarbothioamides, processes for preparation thereof and pharmaceutical compositions comprising the same
CA2073340C (en) * 1990-01-11 1997-05-20 Hakan Vilhelm Wikstrom Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics
WO2000071102A2 (en) * 1999-05-19 2000-11-30 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
MXPA02004330A (es) 1999-11-03 2004-07-30 Albany Molecular Res Inc Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina..
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
KR100821410B1 (ko) * 2000-07-11 2008-04-10 에이엠알 테크놀로지, 인크. 4-페닐 치환된 테트라하이드로이소퀴놀린 및 이의치료학적 용도
MXPA05005586A (es) * 2002-12-02 2005-07-27 Pharmacia & Up John Company Ll El uso de tetrahidroisoquinolinas 4-fenilsustituidas en el tratamiento del dolor, migrana e incontinencia urinaria.
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
US20060111393A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US20060111394A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US20060111385A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
UA95454C2 (uk) * 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
EP2429295B1 (en) 2009-05-12 2013-12-25 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
AU2010247763B2 (en) 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
US8815894B2 (en) 2009-05-12 2014-08-26 Bristol-Myers Squibb Company Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670694B2 (de) * 1966-05-05 1976-07-22 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von tetrahydroisochinolinen
DE2424372C3 (de) * 1974-05-20 1980-09-11 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Isonitrosoacetaniliden

Also Published As

Publication number Publication date
FI843672L (fi) 1985-03-22
PT79220A (en) 1984-10-01
PT79220B (en) 1986-08-22
DK448784D0 (da) 1984-09-20
ZA847400B (en) 1985-06-26
FI843672A0 (fi) 1984-09-19
HUT36119A (en) 1985-08-28
EP0140070A1 (de) 1985-05-08
FI843672A7 (fi) 1985-03-22
ES8605271A1 (es) 1986-03-16
US4564613A (en) 1986-01-14
AU3320184A (en) 1985-03-28
JPS6087256A (ja) 1985-05-16
DK448784A (da) 1985-03-22
KR850002269A (ko) 1985-05-10
ES8603475A1 (es) 1985-12-16
DE3333994A1 (de) 1985-04-04
ES536003A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
ES538721A0 (es) Un procedimiento para preparar derivados de guanina
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES534751A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES545270A0 (es) Un procedimiento para la obtencion de piridoindoles
ES536865A0 (es) Un procedimiento para producir un complejo de platino-diamino
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES533842A0 (es) Un procedimiento para la obtencion de derivados de amino-pirimidina
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES536152A0 (es) Un procedimiento para producir l-arginina
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES537350A0 (es) Un procedimiento para la preparacion de compuestos de -lactama
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES530064A0 (es) Un procedimiento para la obtencion de beta-feniletanoles sustituidos.
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES528692A0 (es) Procedimiento para la obtencion de un complejo glicoesfingolipidico
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES544250A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES536293A0 (es) Un procedimiento para producir derivados de acilindol
ES535847A0 (es) Un procedimiento para producir un uroquinasa-zimogeno
ES534701A0 (es) Un procedimiento para producir l-isoleucina
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina